A randomised sham-controlled double-blind multicenter clinical trial to evaluate the percutaneous Pulsed RadioFrequency treatment at the Dorsal Root Ganglion

Erasmus University Medical Centre (MC) (Netherlands)0 个研究点目标入组 60 人开始时间: 2013年7月23日最近更新: 2020年9月14日

适应症

试验速览

暂无简介。

•1. Age 18 years or older
•2. Anamnesis and physical investigation suggestive of lumbosacral radicular pain for more than 3 months
•3. Decrease in Numeric Rating Scale (NRS) of 2 or more / 10 on diagnostic block at the DRG

•1. Presence of red flags: possible fracture (major trauma, minor trauma in elderly or osteoporotic), possible tumor or infection (age >50 or <20, history of cancer, constitutional symptoms (fever, chills, weight loss), recent bacterial infection, IV drug abuse, immunosuppression, pain worsening at night or when supine), possible significant
•neurological deficit (severe or progressive sensory alteration or weakness, bladder or bowel dysfunction, evidence of neurological deficit (in legs or perineum in the case of low back pain)
•2. Aspecific low back pain
•3. Corpus vertebrae problem
•4. Progressive neurological deficits
•5. Major psychiatric disorder (according to psychiatrists opinion)
•6. Anticoagulation cannot be stopped
•7. Pain in other parts of the body that is more severe (including facet joint -, SI joint - and discogenic pain)
•8. Allergies to any medication used in the study
•9. Pregnancy
•10. Communication (language) difficulties (according to physicians opinion)

发起方

Erasmus University Medical Centre (MC) (Netherlands)